Roser Calvo

Altered HOX and WNT7A expression in human lung cancer

Roser Calvo, James West, Wilbur A. Franklin et al. · Proceedings of the National Academy of Sciences · 2000 · 188 citations

Medicine, Molecular Biology, Oncology +13

Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors

Rafael Rosell, Àlex Pifarré, Mariano Monzó et al. · International Journal of Cancer · 1997 · 64 citations · Full text

Medicine, Genetics, Oncology +17

DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC

Harry A. Drabkin, James West, Marc Hotfilder et al. · Oncogene · 1999 · 45 citations

Life Sciences, Genetics, Molecular Biology +6

A phase 2, multicentre, open‐label trial (<scp>ACE‐LY</scp>‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma

Paolo Strati, Morton Coleman, Rebecca Champion et al. · British Journal of Haematology · 2022 · 30 citations · Full text

Medicine, Oncology, Pharmacology +13

Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis

Michael Wang, Tadeusz Robak, Kami J. Maddocks et al. · Blood Advances · 2024 · 23 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +10